logo
logo
Sign in

Global Orodispersible Tablets Market Is Estimated To Witness High Growth Owing To Growing Preference for Convenient Dosage Forms

avatar
Pooja salve
Global Orodispersible Tablets Market Is Estimated To Witness High Growth Owing To Growing Preference for Convenient Dosage Forms

The global Orodispersible Tablets Market is estimated to be valued at US$ 9.29 Bn in 2022 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Orodispersible tablets, also known as orally disintegrating tablets (ODTs), are gaining significant popularity among patients and healthcare professionals due to their ease of administration. These tablets dissolve quickly in the mouth without the need for water, making them an ideal dosage form for patients who have difficulty in swallowing conventional tablets or capsules. Orodispersible tablets offer several advantages over traditional oral solid dosage forms, including improved patient compliance, enhanced bioavailability, and faster onset of action. With the rising geriatric population and increasing prevalence of chronic diseases, the demand for Orodispersible tablets is expected to witness substantial growth.

Market Key Trends:

One key trend observed in the global Orodispersible Tablets Market is the growing preference for convenient dosage forms. Patients with certain medical conditions, such as dysphagia or pediatric patients who have difficulty swallowing solid medications, find it challenging to adhere to their prescribed treatment regimens. Orodispersible tablets provide a convenient solution as they can be easily administered without the need for water or chewing. For instance, AstraZeneca offers an Orodispersible tablet formulation of its antipsychotic drug, Seroquel, which provides patients with a more convenient and user-friendly option compared to traditional tablet formulations.

PEST Analysis:

- Political: The regulatory environment plays a crucial role in the market for Orodispersible tablets. Governments and regulatory authorities across the globe are focusing on ensuring the safety and efficacy of these dosage forms through stringent regulations and guidelines.

- Economic: The economic factors, such as overall healthcare expenditure and disposable income of the population, influence the demand for Orodispersible tablets. Higher healthcare expenditure and increasing purchasing power are expected to drive market growth.

- Social: The growing geriatric population, who are more susceptible to swallowing difficulties, is a significant social factor driving the demand for Orodispersible tablets. Additionally, the increasing prevalence of chronic diseases and the need for patient-friendly dosage forms contribute to market growth.

- Technological: Technological advancements in formulation development and manufacturing processes have led to the production of Orodispersible tablets with improved stability, taste masking, and rapid disintegration properties. Innovation in drug delivery systems and active packaging technologies are also shaping the market.

Key Takeaways:

Paragraph 1 - The Global Orodispersible Tablets Market Growth is expected to witness high, exhibiting a CAGR of 9.3% over the forecast period, due to increasing demand for convenient dosage forms. The ease of administration and improved patient compliance offered by Orodispersible tablets are driving their adoption.

Paragraph 2 - Regionally, North America is anticipated to dominate the Orodispersible Tablets Market, owing to the presence of key market players, advanced healthcare infrastructure, and high healthcare expenditure. However, the Asia-Pacific region is expected to witness the fastest growth due to the increasing geriatric population and rising awareness about innovative drug delivery systems.

Paragraph 3 - Key players operating in the global Orodispersible Tablets Market include AstraZeneca PLC, GlaxoSmithKline PLC, Novartis International AG, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Pfizer Inc., Cipla Limited, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Inc., Torrent Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Eisai Co., Ltd., and Takeda Pharmaceutical Company Limited. These players are focusing on product development, strategic collaborations, and mergers and acquisitions to expand their market presence and meet the growing demand for Orodispersible tablets.

In conclusion, the global Orodispersible Tablets Market is anticipated to experience significant growth in the coming years due to the increasing preference for convenient dosage forms. The market is driven by factors such as improved patient compliance, ease of administration, and the rising geriatric population. However, stringent regulatory requirements and pricing pressures may pose challenges for market players.

collect
0
avatar
Pooja salve
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more